2027 OPPS Proposed Rule: What Wound Care Clinics Must Know

CMS published the 2027 Outpatient Prospective Payment System (OPPS) proposed rule in August 2026, and its reach extends well beyond hospital billing departments. Any wound care practitioner working in a hospital outpatient department (HOPD), running a wound care program under a facility contract, or billing procedures that cross into the ambulatory surgery center (ASC) covered-procedures list needs to understand the 2027 OPPS proposed rule before January. Reimbursement for wound debridement, skin substitute application, and negative pressure wound therapy in facility settings resets on the OPPS schedule — not the Physician Fee Schedule — and the two systems often move in different directions.

This is a practitioner-level breakdown of what the 2027 OPPS proposed rule means for wound care reimbursement, which Ambulatory Payment Classifications (APCs) are in motion, and how to act before the public comment window closes.

How the OPPS Governs Wound Care Facility Payments

The OPPS pays hospitals for covered outpatient services bundled into APCs. Each APC carries a payment rate set by CMS annually. The rate covers the facility's costs — nursing, equipment, supply overhead — but not the physician or NP/PA professional component, which is paid separately under the Physician Fee Schedule (PFS).

For wound care, this matters because most high-volume procedures have distinct OPPS payment rates that can diverge sharply from PFS work RVU values. When CMS adjusts an APC rate downward, a hospital-affiliated wound care clinic absorbs that cut directly. If you operate under a facility contract or management services agreement, reduced OPPS rates can trigger renegotiations, reduced per-diem contracts, or program closures — even if your clinical outcomes are strong.

The 2027 OPPS proposed rule also governs the ASC covered-procedures list, meaning changes to APCs can affect whether certain wound care procedures remain eligible to perform in an ASC at all. For an independent practice evaluating hospital versus mobile settings, the OPPS rate for a given procedure is a direct input into that financial comparison.

2027 OPPS Proposed Rule: Key Wound Care APC Changes

CMS organizes OPPS payments around APCs with multiple procedures grouped by clinical and cost similarity. For wound care, the APCs that warrant close reading in the 2027 proposed rule fall into four categories.

Debridement APCs

Excisional debridement (CPT 11042–11047) and selective debridement (CPT 97597–97598) are typically assigned to Level 3 or Level 4 Minor Surgery APCs depending on the depth and extent of tissue removed. CMS's cost modeling for these APCs uses hospital claims data from two years prior — meaning 2027 rates reflect cost patterns from fiscal year 2024–2025 hospital cost reports.

The key variable to track in the proposed rule is whether CMS is proposing any APC reassignment for debridement codes. An upward reclassification into a higher-level APC improves facility payment; a downward move or a packaging change (where debridement becomes incidental to a higher-complexity procedure) can suppress the rate significantly. Wound care program directors negotiating per-procedure contracts with hospitals need the proposed and final OPPS rate tables as a baseline — the wound care CPT codes 2026 guide covers the procedure-level context, but the facility payment sits on top.

Skin Substitute APCs and the 2026 Flat-Rate Transition

This is the highest-stakes area in the 2027 OPPS proposed rule for wound care billing. CMS finalized its skin substitute flat-rate payment model for 2026, replacing the prior product-specific pass-through payment system. The 2026 implementation generated significant claims data that CMS is now using to recalibrate facility OPPS payments for 2027.

Two questions dominate this section of the proposed rule:

Will the flat rate hold or move? The 2026 flat rate for the skin substitute high-cost group effectively capped the facility's product cost reimbursement. If CMS's analysis of 2025 claims shows that the flat rate created systematic under-recovery for high-cost products, you can expect an upward adjustment. Conversely, if utilization shifted heavily toward lower-cost products within the high-cost group, CMS may reduce the rate or restructure the groupings.

How are the APC assignments structured for 2027? The 2027 proposed rule can shift which products qualify for which payment group and set different co-insurance rates for patients — a direct driver of patient cost-sharing that affects practice economics. The skin substitute billing guide remains the reference for the product-level coding logic; the OPPS rate is the facility-side dollar attached to each APC assignment.

NPWT Facility-Rate Changes

Negative pressure wound therapy (NPWT) billed in hospital outpatient settings is subject to the OPPS rates, not the DME rates that apply to home-based NPWT. CMS periodically reviews the NPWT APCs based on updated cost data, and the 2027 proposed rule may adjust rates for disposable NPWT devices as the clinical market continues to shift toward single-use systems.

The gap between HOPD-based NPWT reimbursement and professional-component billing has historically made NPWT one of the more complex services to align across facility and physician billing cycles. Understanding the proposed OPPS rate for NPWT APCs gives you the facility-side component needed to assess whether providing NPWT in an outpatient hospital setting remains economically rational.

Packaging and Bundling Proposals

The 2027 proposed rule typically includes updates to CMS's comprehensive APC (C-APC) packaging policy. When a wound care procedure is packaged into a higher-level C-APC — such as a surgical debridement performed on the same day as a more complex surgical service — the debridement may pay zero separately and be absorbed into the primary APC rate. This is a direct revenue risk for wound care programs that operate within larger outpatient surgical departments.

Review the proposed packaging changes against your actual encounter patterns. If your wound care program consistently performs debridement alongside vascular or orthopedic procedures in the same outpatient encounter, packaging changes can materially reduce per-visit facility collections — a variable that affects any wound care revenue model analysis.

How to Use the Proposed Rule Before the Comment Deadline

CMS accepts public comments on the OPPS proposed rule through late September 2026. Submitting a comment is not a bureaucratic exercise — CMS responds to substantive comments with data in the final rule, and organizations that submit comments with claims-level backup routinely influence APC reassignments.

Here is a practical comment-submission workflow for wound care program operators:

Pull your facility claims data for the relevant APCs. Run an encounter-level report for the 12 months prior, grouped by APC assignment. Identify any APC that represents more than 10% of your facility volume.
Calculate the dollar impact of the proposed rate change. Multiply the proposed rate delta by your encounter count. A $45 APC rate reduction on 200 monthly debridement encounters equals $108,000 in annual facility revenue — a number worth fighting for.
Compare the proposed rate to reported hospital cost data. If the proposed rate falls below your facility's documented cost for that APC, that's the core of a cost-based comment.
Submit through the Federal Register comment portal at regulations.gov, referencing the CMS docket number for the 2027 OPPS proposed rule. Include your facility name, patient volume, and specific APC designations.

Independent wound care practices without direct HOPD billing still benefit from understanding these rates: practice revenue model planning for mobile and community-based programs is sharpened when you understand what the facility alternative pays, and facility-contract negotiations go better when you can reference published rates.

Key Takeaways

The 2027 OPPS proposed rule sets facility-side APC rates for wound debridement, skin substitute application, and NPWT in hospital outpatient and ASC settings — separate from and often divergent from PFS professional-component rates.
The skin substitute APC section is the highest-stakes area: CMS can adjust flat-rate groupings, payment levels, and product eligibility based on 2025 claims data from the first year of the flat-rate model.
Packaging proposals can suppress debridement and wound care APC payments to zero when those procedures co-occur with higher-complexity surgical services on the same outpatient encounter.
Public comments close in late September 2026; submitting encounter-level cost data can influence APC assignments in the November final rule.
Independent wound care practices without HOPD billing should track OPPS rates as a benchmark for facility-contract negotiations and competitive positioning against hospital-based programs.